Literature DB >> 23190795

Elevated serum fibroblast growth factor 21 is associated with hypertension in community-dwelling adults.

R D Semba, C Crasto, J Strait, K Sun, D A Schaumberg, L Ferrucci.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23190795      PMCID： PMC4059993          DOI： 10.1038/jhh.2012.52

Source DB:  PubMed          Journal:  J Hum Hypertens        ISSN： 0950-9240            Impact factor:   3.012


× No keyword cloud information.
  11 in total

Review 1.  Under pressure: the search for the essential mechanisms of hypertension.

Authors:  Thomas M Coffman
Journal:  Nat Med       Date:  2011-11-07       Impact factor: 53.440

Review 2.  Arterial stiffness and hypertension: a two-way street?

Authors:  Stanley S Franklin
Journal:  Hypertension       Date:  2005-02-14       Impact factor: 10.190

3.  Serum fibroblast growth factor-21 concentration is associated with residual renal function and insulin resistance in end-stage renal disease patients receiving long-term peritoneal dialysis.

Authors:  Seung Hyeok Han; Sung Hee Choi; Bong Jun Cho; Yenna Lee; Soo Lim; Young Joo Park; Min Kyung Moon; Hong Kyu Lee; Shin-Wook Kang; Dae Suk Han; Young-Bum Kim; Hak C Jang; Kyong Soo Park
Journal:  Metabolism       Date:  2010-04-27       Impact factor: 8.694

4.  Serum fibroblast growth factor 21 was elevated in subjects with type 2 diabetes mellitus and was associated with the presence of carotid artery plaques.

Authors:  So-Yeon An; Min Suk Lee; Sang-A Yi; Eun Suk Ha; Seung Jin Han; Hae Jin Kim; Dae Jung Kim; Kwan-Woo Lee
Journal:  Diabetes Res Clin Pract       Date:  2012-01-30       Impact factor: 5.602

5.  FGF21 reloaded: challenges of a rapidly growing field.

Authors:  Alexei Kharitonenkov; Philip Larsen
Journal:  Trends Endocrinol Metab       Date:  2010-12-29       Impact factor: 12.015

6.  Effects of a three-month combined exercise programme on fibroblast growth factor 21 and fetuin-A levels and arterial stiffness in obese women.

Authors:  Sae Jeong Yang; Ho Cheol Hong; Hae Yoon Choi; Hye Jin Yoo; Geum Ju Cho; Teak Geun Hwang; Sei Hyun Baik; Dong Seop Choi; Seon Mi Kim; Kyung Mook Choi
Journal:  Clin Endocrinol (Oxf)       Date:  2011-10       Impact factor: 3.478

Review 7.  Fibroblast growth factor 21: from pharmacology to physiology.

Authors:  Steven A Kliewer; David J Mangelsdorf
Journal:  Am J Clin Nutr       Date:  2009-11-11       Impact factor: 7.045

8.  Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity.

Authors:  K G M M Alberti; Robert H Eckel; Scott M Grundy; Paul Z Zimmet; James I Cleeman; Karen A Donato; Jean-Charles Fruchart; W Philip T James; Catherine M Loria; Sidney C Smith
Journal:  Circulation       Date:  2009-10-05       Impact factor: 29.690

9.  Serum FGF21 levels are increased in obesity and are independently associated with the metabolic syndrome in humans.

Authors:  Xinmei Zhang; Dennis C Y Yeung; Michal Karpisek; David Stejskal; Zhi-Guang Zhou; Feng Liu; Rachel L C Wong; Wing-Sun Chow; Annette W K Tso; Karen S L Lam; Aimin Xu
Journal:  Diabetes       Date:  2008-02-05       Impact factor: 9.461

10.  Serum levels of FGF-21 are increased in coronary heart disease patients and are independently associated with adverse lipid profile.

Authors:  Zhuofeng Lin; Zhen Wu; Xiaojing Yin; Yanlong Liu; Xinxin Yan; Shaoqiang Lin; Jian Xiao; Xiaojie Wang; Wenke Feng; Xiaokun Li
Journal:  PLoS One       Date:  2010-12-29       Impact factor: 3.240
View more
  31 in total

1.  Fibroblast growth factor 21 protects the heart from apoptosis in a diabetic mouse model via extracellular signal-regulated kinase 1/2-dependent signalling pathway.

Authors:  Chi Zhang; Zhifeng Huang; Junlian Gu; Xiaoqing Yan; Xuemian Lu; Shanshan Zhou; Shudong Wang; Minglong Shao; Fangfang Zhang; Peng Cheng; Wenke Feng; Yi Tan; Xiaokun Li
Journal:  Diabetologia       Date:  2015-06-04       Impact factor: 10.122

2.  Association of elevated circulating fibroblast growth factor 21 levels with prevalent and incident metabolic syndrome: The Multi-Ethnic Study of Atherosclerosis.

Authors:  Kwok-Leung Ong; Robyn L McClelland; Matthew A Allison; John Kokkinos; Ben J Wu; Philip J Barter; Kerry-Anne Rye
Journal:  Atherosclerosis       Date:  2018-10-17       Impact factor: 5.162

Review 3.  The Potential Role of Fibroblast Growth Factor 21 in Lipid Metabolism and Hypertension.

Authors:  Zhe Huang; Aimin Xu; Bernard M Y Cheung
Journal:  Curr Hypertens Rep       Date:  2017-04       Impact factor: 5.369

4.  The relationship of circulating fibroblast growth factor 21 levels with incident atrial fibrillation: The Multi-Ethnic Study of Atherosclerosis.

Authors:  Tsz Him Hui; Robyn L McClelland; Matthew A Allison; Carlos J Rodriguez; Richard A Kronmal; Susan R Heckbert; Erin D Michos; Philip J Barter; Kerry-Anne Rye; Kwok Leung Ong
Journal:  Atherosclerosis       Date:  2017-12-25       Impact factor: 5.162

Review 5.  The roles of FGF21 in atherosclerosis pathogenesis.

Authors:  Farzane Shanebandpour Tabari; Ansar Karimian; Hadi Parsian; Vahid Rameshknia; Ata Mahmoodpour; Maryam Majidinia; Mahmood Maniati; Bahman Yousefi
Journal:  Rev Endocr Metab Disord       Date:  2019-03       Impact factor: 6.514

Review 6.  Cardiac actions of fibroblast growth factor 23.

Authors:  Christian Faul
Journal:  Bone       Date:  2016-10-07       Impact factor: 4.398

7.  The metabolic hormone FGF21 is associated with endothelial dysfunction in hemodialysis patients.

Authors:  Crina Claudia Rusu; Simona Racasan; Ina Maria Kacso; Diana Moldovan; Alina Potra; Dacian Tirinescu; Cristian Budurea; Remus Orasan; Ioan Mihai Patiu; Cosmina Ioana Bondor; Dan Vladutiu; Mirela Gherman Caprioara
Journal:  Int Urol Nephrol       Date:  2016-12-10       Impact factor: 2.370

8.  Possible role of fibroblast growth factor 21 on atherosclerosis via amelioration of endoplasmic reticulum stress-mediated apoptosis in apoE(-/-) mice.

Authors:  Xi Wu; Yong-Fen Qi; Jin-Rui Chang; Wei-Wei Lu; Jin-Sheng Zhang; Shao-Ping Wang; Shu-Juan Cheng; Ming Zhang; Qian Fan; Yuan Lv; Hui Zhu; Man-Kun Xin; Yun Lv; Jing-Hua Liu
Journal:  Heart Vessels       Date:  2014-08-05       Impact factor: 2.037

Review 9.  Fibroblast growth factors in cardiovascular disease: The emerging role of FGF21.

Authors:  Eleni M Domouzoglou; Katerina K Naka; Antonios P Vlahos; Michail I Papafaklis; Lampros K Michalis; Agathoklis Tsatsoulis; Eleftheria Maratos-Flier
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-07-31       Impact factor: 4.733

Review 10.  Adipose Tissue and Modulation of Hypertension.

Authors:  Eashita Das; Joon Ho Moon; Ju Hee Lee; Nikita Thakkar; Zdenka Pausova; Hoon-Ki Sung
Journal:  Curr Hypertens Rep       Date:  2018-09-18       Impact factor: 5.369
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.